Skip to main content
Top
Published in: Annals of Hematology 9/2006

01-09-2006 | Original Article

Congenital dyserythropoietic anemia type I with bone abnormalities, mutations of the CDAN I gene, and significant responsiveness to alpha-interferon therapy

Authors: Jeroen S. Goede, Rudolf Benz, Joerg Fehr, Klaus Schwarz, Hermann Heimpel

Published in: Annals of Hematology | Issue 9/2006

Login to get access

Abstract

Congenital dyserythropoietic anemia type I (CDA I) is a rare autosomal recessive disorder with ineffective erythropoiesis, characteristic morphological abnormalities of erythroblasts, and iron overloading. CDA I is caused by mutations in the CDAN I gene, encoding a protein named codanin-1. Complex bone abnormalities, especially syndactyly, have not been systematically described with this disease. We present two cases of morphologically and genetically confirmed CDA I with striking bone abnormalities and response to treatment with alpha-interferon. Our cases clearly document the association of skeletal anomalism with CDA I and indicate that codanin-1 may play a role in the development of the skeleton.
Literature
1.
go back to reference Delaunay J, Iolascon A (1999) The congenital dyserythropoietic anemias. Bailliere’s Best Pract Res Clin Haematol 12(4):691–705CrossRef Delaunay J, Iolascon A (1999) The congenital dyserythropoietic anemias. Bailliere’s Best Pract Res Clin Haematol 12(4):691–705CrossRef
2.
go back to reference Heimpel H (2004) Congenital dyserythropoietic anemias: epidemiology, clinical significance and progress in understanding their pathogenesis. Ann Hematol 83(9):613–621PubMed Heimpel H (2004) Congenital dyserythropoietic anemias: epidemiology, clinical significance and progress in understanding their pathogenesis. Ann Hematol 83(9):613–621PubMed
3.
go back to reference Heimpel H, Schwarz K, Ebnöther M, Goede JS, Heydrich D, Kamp T, Lothar P, Rath B, Roessler J, Schildknecht O, Schmid M, Wuillemin W, Einsiedler B, Leichtle R, Tamary H, Kohne E (2006) Congenital dyserythropoietic anemia type I (CDA I): molecular genetics, clinical appearance and prognosis based on long-term observation. Blood 107(1):334–340PubMedCrossRef Heimpel H, Schwarz K, Ebnöther M, Goede JS, Heydrich D, Kamp T, Lothar P, Rath B, Roessler J, Schildknecht O, Schmid M, Wuillemin W, Einsiedler B, Leichtle R, Tamary H, Kohne E (2006) Congenital dyserythropoietic anemia type I (CDA I): molecular genetics, clinical appearance and prognosis based on long-term observation. Blood 107(1):334–340PubMedCrossRef
4.
go back to reference Wickramasinghe SN, Wood WG (2005) Advances in the understanding of the congenital dyserythropoietic anemias. Br J Haematol 131(4):431–446PubMedCrossRef Wickramasinghe SN, Wood WG (2005) Advances in the understanding of the congenital dyserythropoietic anemias. Br J Haematol 131(4):431–446PubMedCrossRef
5.
go back to reference Dgany O, Avidan N, Delaunay J, Krasnov T, Shalmon L, Shalev H, Eidelitz-Markus T, Kapelushnik J, Cattan D, Pariente A, Tulliez M, Cretien A, Schischmanoff PO, Iolascon A, Fibach E, Koren A, Rossler J, Le Merrer M, Yaniv I, Zaizov R, Ben-Asher E, Olender T, Lancet D, Beckmann JS, Tamary H (2002) Congenital dyserythropoietic anemia type I is caused by mutations in codanin-1. Am J Hum Genet 71(6):1467–1474PubMedCrossRef Dgany O, Avidan N, Delaunay J, Krasnov T, Shalmon L, Shalev H, Eidelitz-Markus T, Kapelushnik J, Cattan D, Pariente A, Tulliez M, Cretien A, Schischmanoff PO, Iolascon A, Fibach E, Koren A, Rossler J, Le Merrer M, Yaniv I, Zaizov R, Ben-Asher E, Olender T, Lancet D, Beckmann JS, Tamary H (2002) Congenital dyserythropoietic anemia type I is caused by mutations in codanin-1. Am J Hum Genet 71(6):1467–1474PubMedCrossRef
6.
go back to reference Tamary H, Dgany O, Proust A, Krasnov T, Avidan N, Eidelitz-Markus T, Tchernia G, Genevieve D, Cormier-Daire V, Bader-Meunier B, Ferrer-Vacher C, Munzer M, Gruppo R, Fibach E, Konen O, Yanif I, Delaunay J (2005) Clinical and molecular variability in congenital dyserythropoietic anemia type I. Br J Haematol 130(4):628–634PubMedCrossRef Tamary H, Dgany O, Proust A, Krasnov T, Avidan N, Eidelitz-Markus T, Tchernia G, Genevieve D, Cormier-Daire V, Bader-Meunier B, Ferrer-Vacher C, Munzer M, Gruppo R, Fibach E, Konen O, Yanif I, Delaunay J (2005) Clinical and molecular variability in congenital dyserythropoietic anemia type I. Br J Haematol 130(4):628–634PubMedCrossRef
7.
go back to reference Tamary H, Shalmon L, Shalev H, Shaft D, Zoldan M, Resnitzky P, Korostishevky M, Zaizov R (1996) Localisation of the gene for congenital dyserythropoietic anemia type I to chromosome 15q15.1.3. Blood 88(Suppl 1):144 Tamary H, Shalmon L, Shalev H, Shaft D, Zoldan M, Resnitzky P, Korostishevky M, Zaizov R (1996) Localisation of the gene for congenital dyserythropoietic anemia type I to chromosome 15q15.1.3. Blood 88(Suppl 1):144
8.
go back to reference Shalev H, Kapelushnik J, Moser A, Dgany O, Krasnov T, Tamary H (2004) A comprehensive study of the neonatal manifestations of congenital dyserythropoietic anemia type I. J Pediatr Hematol Oncol 26(11):746–748PubMedCrossRef Shalev H, Kapelushnik J, Moser A, Dgany O, Krasnov T, Tamary H (2004) A comprehensive study of the neonatal manifestations of congenital dyserythropoietic anemia type I. J Pediatr Hematol Oncol 26(11):746–748PubMedCrossRef
9.
go back to reference Holmberg L, Jansson L, Rausing A, Henriksson P (1978) Type I congenital dyserythropoietic anemia with myelopoietic abnormalities and hand malformations. Scand J Haematol 21:72–79PubMedCrossRef Holmberg L, Jansson L, Rausing A, Henriksson P (1978) Type I congenital dyserythropoietic anemia with myelopoietic abnormalities and hand malformations. Scand J Haematol 21:72–79PubMedCrossRef
10.
go back to reference Brichard B, Vermylen C, Scheiff JM, Michaux JL, Ninane J, Cornu G (1994) Two cases of congenital dyserythropoietic anemia type I associated with unusual skeletal abnormalities of the limbs. Br J Haematol 86:201–202PubMedCrossRef Brichard B, Vermylen C, Scheiff JM, Michaux JL, Ninane J, Cornu G (1994) Two cases of congenital dyserythropoietic anemia type I associated with unusual skeletal abnormalities of the limbs. Br J Haematol 86:201–202PubMedCrossRef
11.
go back to reference Le Merrer M, Girot R, Parent P, Cormier Daire V, Maroteaux P (1995) Acral dysostosis dyserythropoiesis syndrome. Eur J Pediatr 154:384–388PubMedCrossRef Le Merrer M, Girot R, Parent P, Cormier Daire V, Maroteaux P (1995) Acral dysostosis dyserythropoiesis syndrome. Eur J Pediatr 154:384–388PubMedCrossRef
12.
go back to reference Sabry MA, Zaki M, al Awadi SA, al Saleh Q, Mattar MS (1997) Non-haematological traits associated with congenital dyserythropoietic anemia type 1: a new entity emerging. Clin Dysmorph 6(3):205–212PubMedCrossRef Sabry MA, Zaki M, al Awadi SA, al Saleh Q, Mattar MS (1997) Non-haematological traits associated with congenital dyserythropoietic anemia type 1: a new entity emerging. Clin Dysmorph 6(3):205–212PubMedCrossRef
13.
go back to reference Wickramasinghe SN (1998) Congenital dyserythropoietic anemias: clinical features, haematological morphology and new biochemical data. Blood Rev 12:178–200PubMedCrossRef Wickramasinghe SN (1998) Congenital dyserythropoietic anemias: clinical features, haematological morphology and new biochemical data. Blood Rev 12:178–200PubMedCrossRef
14.
go back to reference Roda L, Pasche J, Fournier A, Terorotua V, Wickramasinghe SN, Tamary H, Schischmanoff PO, Tchernia G, Delaunay J (2002) Congenital dyserythropoietic anemia, type 1, in a Polynesian patient: response to interferon alpha2b. J Pediatr Hematol Oncol 24(6):503–506PubMedCrossRef Roda L, Pasche J, Fournier A, Terorotua V, Wickramasinghe SN, Tamary H, Schischmanoff PO, Tchernia G, Delaunay J (2002) Congenital dyserythropoietic anemia, type 1, in a Polynesian patient: response to interferon alpha2b. J Pediatr Hematol Oncol 24(6):503–506PubMedCrossRef
15.
16.
go back to reference Tamary H, Dgany O, Proust A, Krasnov T, Avidan N, Tschernia G, Genevieve D, Comier-Darre V, Le Merrer M, Bader-Meunier B, Ferrero-Vacher C, Yaniv, I, Delaunay J (2004) Molecular basis of congenital dyserythropoietic anemia type I in French patients. Blood 104(11):13b Tamary H, Dgany O, Proust A, Krasnov T, Avidan N, Tschernia G, Genevieve D, Comier-Darre V, Le Merrer M, Bader-Meunier B, Ferrero-Vacher C, Yaniv, I, Delaunay J (2004) Molecular basis of congenital dyserythropoietic anemia type I in French patients. Blood 104(11):13b
17.
go back to reference Pielage J, Stork T, Bunse I, Klambt C (2003) The Drosophila cell survival gene discs lost encodes a cytoplasmic codanin-1-like protein, not a homolog of tight junction PDZ protein Patj. Dev Cell 5(6):841–851PubMedCrossRef Pielage J, Stork T, Bunse I, Klambt C (2003) The Drosophila cell survival gene discs lost encodes a cytoplasmic codanin-1-like protein, not a homolog of tight junction PDZ protein Patj. Dev Cell 5(6):841–851PubMedCrossRef
18.
go back to reference Marwaha RK, Bansal D, Trehan A, Garewal G (2005) Interferon therapy in congenital dyserythropoietic anemia type I/II. Pediatr Hematol Oncol 22(2):133–138PubMedCrossRef Marwaha RK, Bansal D, Trehan A, Garewal G (2005) Interferon therapy in congenital dyserythropoietic anemia type I/II. Pediatr Hematol Oncol 22(2):133–138PubMedCrossRef
19.
go back to reference Lavabre-Bertrand T, Ramos J, Delfour C, Henry L, Guiraud I, Carillo S, Wagner A, Bureau JP, Blanc P (2004) Long-term alpha interferon treatment is effective on anemia and significantly reduces iron overload in congenital dyserythropoiesis type I. Eur J Haematol 73(5):380–383PubMedCrossRef Lavabre-Bertrand T, Ramos J, Delfour C, Henry L, Guiraud I, Carillo S, Wagner A, Bureau JP, Blanc P (2004) Long-term alpha interferon treatment is effective on anemia and significantly reduces iron overload in congenital dyserythropoiesis type I. Eur J Haematol 73(5):380–383PubMedCrossRef
Metadata
Title
Congenital dyserythropoietic anemia type I with bone abnormalities, mutations of the CDAN I gene, and significant responsiveness to alpha-interferon therapy
Authors
Jeroen S. Goede
Rudolf Benz
Joerg Fehr
Klaus Schwarz
Hermann Heimpel
Publication date
01-09-2006
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 9/2006
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-006-0143-z

Other articles of this Issue 9/2006

Annals of Hematology 9/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.